Clinical significance of circulating tumor cells in patients with small-cell lung cancer

被引:6
|
作者
Wang, Yu-Li [1 ]
Liu, Chun-Hua [2 ]
Li, Jing [3 ]
Ma, Xiao-Ping [3 ]
Gong, Ping [3 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Dept Oncol, Wuhan, Peoples R China
[2] Peoples Hosp Xinjiang Uygyr Autonomous Reg, Dept Radiat Oncol, Uygyr, Peoples R China
[3] Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, 107 North Two Rd, Shihezi 832008, Peoples R China
来源
TUMORI JOURNAL | 2017年 / 103卷 / 03期
关键词
Circulating tumor cells; Clinical characteristics; Prognosis; Progression-free survival; Small-cell lung cancer; METASTATIC BREAST-CANCER; PERIPHERAL-BLOOD; SURVIVAL; PROGRESSION; END;
D O I
10.5301/tj.5000601
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: This study investigated the correlation of the presence of circulating tumor cells (CTCs) with clinical characteristics, and the predictive value of CTCs for progression-free survival (PFS) in patients with small-cell lung cancer (SCLC). Methods: Samples were obtained from 42 patients with SCLC before and after the first cycle of chemotherapy. CTCs were quantitated by negative immunomagnetic enrichment and immunocytochemistry using anti-CD45 and anti-pancytokeratin antibodies. Results: CTCs were positive (>= 2) in 76.19% of patients with SCLC and negative in the control group. The presence of CTCs was positively correlated with 6 clinical characteristics. PFS was 6.055 and 10.670 months for patients with >= 2 and <2 CTCs/7.5 mL of blood before chemotherapy; after chemotherapy PFS was 4.862 and 10.535 months, respectively. Conclusions: This study showed that both baseline CTC numbers and the change in CTC numbers after 1 cycle of chemotherapy are significant prognostic factors of PFS for SCLC.
引用
收藏
页码:242 / 248
页数:7
相关论文
共 50 条
  • [1] CLINICAL SIGNIFICANCE OF CIRCULATING TUMOR CELLS IN PATIENTS WITH SMALL-CELL LUNG CANCER
    Gong, P.
    Liu, C.
    Shihezi, Y.
    Yang, Z.
    Li, J.
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [2] Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
    Hou, Jian-Mei
    Krebs, Matthew G.
    Lancashire, Lee
    Sloane, Robert
    Backen, Alison
    Swain, Rajeeb K.
    Priest, Lynsey J. C.
    Greystoke, Alastair
    Zhou, Cong
    Morris, Karen
    Ward, Tim
    Blackhall, Fiona H.
    Dive, Caroline
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05) : 525 - 532
  • [3] Prognostic Significance of Circulating Tumor Cells in Small-Cell Lung Cancer Patients: a Meta-analysis
    Zhang, Jiao
    Wang, Hai-Tao
    Li, Bao-Guo
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (19) : 8429 - 8433
  • [4] THE USEFULNESS OF MEASURING CIRCULATING TUMOR CELLS IN PATIENTS WITH SMALL-CELL LUNG CANCER
    Naito, T.
    Tanaka, F.
    Yoneda, K.
    Takahashi, T.
    Murakami, H.
    Nakamura, Y.
    Tsuya, A.
    Endo, M.
    Ono, A.
    Yamamoto, N.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 72 - 72
  • [5] Clinical significance of circulating tumor cells in squamous cell lung cancer patients
    Qi, Yuanling
    Wang, Wenhui
    [J]. CANCER BIOMARKERS, 2017, 18 (02) : 161 - 167
  • [6] Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer
    Normanno, Nicola
    Rossi, Antonio
    Morabito, Alessandro
    Signoriello, Simona
    Beviacqua, Simona
    Di Maio, Massimo
    Costanzo, Raffaele
    De Luca, Antonella
    Montanino, Agnese
    Gridelli, Cesare
    Rocco, Gaetano
    Perrone, Francesco
    Gallo, Ciro
    [J]. LUNG CANCER, 2014, 85 (02) : 314 - 319
  • [7] Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
    Hodgkinson, Cassandra L.
    Morrow, Christopher J.
    Li, Yaoyong
    Metcalf, Robert L.
    Rothwell, Dominic G.
    Trapani, Francesca
    Polanski, Radoslaw
    Burt, Deborah J.
    Simpson, Kathryn L.
    Morris, Karen
    Pepper, Stuart D.
    Nonaka, Daisuke
    Greystoke, Alastair
    Kelly, Paul
    Bola, Becky
    Krebs, Matthew G.
    Antonello, Jenny
    Ayub, Mahmood
    Faulkner, Suzanne
    Priest, Lynsey
    Carter, Louise
    Tate, Catriona
    Miller, Crispin J.
    Blackhall, Fiona
    Brady, Ged
    Dive, Caroline
    [J]. NATURE MEDICINE, 2014, 20 (08) : 897 - 903
  • [8] Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
    Cassandra L Hodgkinson
    Christopher J Morrow
    Yaoyong Li
    Robert L Metcalf
    Dominic G Rothwell
    Francesca Trapani
    Radoslaw Polanski
    Deborah J Burt
    Kathryn L Simpson
    Karen Morris
    Stuart D Pepper
    Daisuke Nonaka
    Alastair Greystoke
    Paul Kelly
    Becky Bola
    Matthew G Krebs
    Jenny Antonello
    Mahmood Ayub
    Suzanne Faulkner
    Lynsey Priest
    Louise Carter
    Catriona Tate
    Crispin J Miller
    Fiona Blackhall
    Ged Brady
    Caroline Dive
    [J]. Nature Medicine, 2014, 20 : 897 - 903
  • [9] Protection of small-cell lung cancer circulating tumor cells by cellular fragmentation
    Rath, Barbara
    Plangger, Adelina
    Moser, Doris
    Hochmair, Maximilian
    Ulsperger, Ernst
    Hamilton, Gerhard
    [J]. JOURNAL OF CANCER METASTASIS AND TREATMENT, 2020, 6
  • [10] Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
    Hiltermann, T. J. N.
    Pore, M. M.
    van den Berg, A.
    Timens, W.
    Boezen, H. M.
    Liesker, J. J. W.
    Schouwink, J. H.
    Wijnands, W. J. A.
    Kerner, G. S. M. A.
    Kruyt, F. A. E.
    Tissing, H.
    Tibbe, A. G. J.
    Terstappen, L. W. M. M.
    Groen, H. J. M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (11) : 2937 - 2942